4
Changes in Ownership
AEON Biopharma, Inc. Filed Acc 0001104659-23-083570
Options or other derivatives
- CLO and Corporate Secretary acquired 278,340 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wilson Alexander Blair · CLO and Corporate Secretary
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-21 | Grant or award : show line 1 in the form Stock Option | +77,647 | 77,647 | D |
| 2023-07-21 | Grant or award : show line 2 in the form Stock Option | +12,656 | 12,656 | D |
| 2023-07-21 | Grant or award : show line 3 in the form Stock Option | +106,609 | 106,609 | D |
| 2023-07-21 | Grant or award : show line 4 in the form Restricted Stock Units | +81,428 | 81,428 | D |
Loading xslF345X05/tm2321918-12_4seq1.xml…